Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stiefel's MaxClarity "More Medicine," Severe Acne Claims Irritate Competitor

Executive Summary

Stiefel Laboratories' claims suggesting that its exclusive MaxClarity foam-based system can treat severe acne by delivering more medicine than alternative products without irritation did not sit well with the competition
Advertisement

Related Content

For Murad Acne Complex Ads, ERSP Draws Line Between “Clear” And “Clears”
For Murad Acne Complex Ads, ERSP Draws Line Between “Clear” And “Clears”
MaxClarity Delivers Anti-Acne Actives Via Penetration-Enhancing Foam
MaxClarity Delivers Anti-Acne Actives Via Penetration-Enhancing Foam
Advertisement
UsernamePublicRestriction

Register

RS017234

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel